Search Results - "Jaen, P"

Refine Results
  1. 1

    Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers by Moreno‐Arrones, O.M., Serrano‐Villar, S., Perez‐Brocal, V., Saceda‐Corralo, D., Morales‐Raya, C., Rodrigues‐Barata, R., Moya, A., Jaen‐Olasolo, P., Vano‐Galvan, S.

    “…Background Alopecia areata is a T‐cell‐mediated autoimmune disease with an unknown etiopathogenesis. Gut microbiota has been revealed as a key modulator of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Videodermoscopy and doppler‐ultrasound in spider naevi: towards a new classification? by Alegre‐Sánchez, A., Bernárdez, C., Fonda‐Pascual, P., Moreno‐Arrones, O.M., López‐Gutiérrez, J.C., Jaén‐Olasolo, P., Boixeda, P.

    “…Introduction Spider naevi (SN) are considered a subtype of telangiectasias, currently classified as low‐flow vascular malformations. Objective To describe the…”
    Get full text
    Journal Article
  7. 7

    Anemia and Mucocutaneous Telangiectasias by Grillo, E., MD, Miguel-Morrondo, A., MD, Jaén-Olasolo, P., PhD

    Published in American family physician (15-01-2014)
    “…A hereditary hemorrhagic telangiectasia diagnosis is clinical and based on the Curacao criteria: spontaneous, recurrent epistaxis; multiple mucocutaneous…”
    Get full text
    Journal Article
  8. 8

    Dynamic skin changes of acute radiation dermatitis revealed by in vivo reflectance confocal microscopy by Vano-Galvan, S., Fernandez-Lizarbe, E., Truchuelo, M., Diaz-Ley, B., Grillo, E., Sanchez, V., Ríos-Buceta, L., Paoli, J., Sancho, S., Montero, A., Hernanz, R., Ramos, A., Jaen, P., Gonzalez, S.

    “…Background  A better knowledge of the dynamic biological changes that the skin undergoes in response to ionizing radiation is advisable to improve the…”
    Get full text
    Journal Article
  9. 9

    The place of botulinum toxin type A in the treatment of focal hyperhidrosis by LOWE, N., CAMPANATI, A., BODOKH, I., CLIFF, S., JAEN, P., KREYDEN, O., NAUMANN, M., OFFIDANI, A., VADOUD, J., HAMM, H.

    Published in British journal of dermatology (1951) (01-12-2004)
    “…Summary Background  Hyperhidrosis (primary or secondary) is excessive sweating beyond that required to return body temperature to normal. It can be localized…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis by Alvarez-Twose, I., Vañó-Galván, S., Sánchez-Muñoz, L., Morgado, J. M., Matito, A., Torrelo, A., Jaén, P., Schwartz, L. B., Orfao, A., Escribano, L.

    Published in Allergy (Copenhagen) (01-06-2012)
    “…Background Despite the good prognosis of pediatric mastocytosis, some patients suffer from severe mast cell (MC) mediator‐associated symptoms. The aim of this…”
    Get full text
    Journal Article
  12. 12

    Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers by Bagazgoitia, L., Cuevas Santos, J., Juarranz, Á., Jaén, P.

    Published in British journal of dermatology (1951) (01-07-2011)
    “…Summary Background  Photodynamic therapy (PDT) has been shown to be effective in treating nonmelanoma skin cancer (NMSC), especially actinic keratosis (AK)…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Parametric lightweight design of a direct-drive wind turbine electrical generator supporting structure for minimising dynamic response by Jaen-Sola, P., Oterkus, E., McDonald, A. S.

    Published in Ships and offshore structures (18-08-2021)
    “…Heavy, large and robust supporting structures are needed to keep the airgap clearance of direct-drive multi-MW wind turbine electrical generators open and…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) - part I: upper facial wrinkles by Ascher, B, Talarico, S, Cassuto, D, Escobar, S, Hexsel, D, Jaén, P, Monheit, GD, Rzany, B, Viel, M

    “…Background  Azzalure (Galderma SA) is a newly approved European botulinum neurotoxin type A (BoNT‐A). It is derived from Dysport (Ipsen Pharma), which has a…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit) - part II: wrinkles on the middle and lower face, neck and chest by Ascher, B, Talarico, S, Cassuto, D, Escobar, S, Hexsel, D, Jaén, P, Monheit, GD, Rzany, B, Viel, M

    “…Background  Azzalure® (Galderma SA), a newly approved European botulinum neurotoxin type A (BoNT‐A), is derived from Dysport™ (Ipsen Ltd.), which has a 20‐year…”
    Get full text
    Journal Article